This website uses cookies to ensure you get the best experience on our website.
Privacy Statement

ABOUT US

HCMED INNOVATIONS PROVIDES A COMPREHENSIVE DRUG-DEVICE COMBINATION PLATFORM BUILT ON ITS CORE PRODUCT PORTFOLIO OF VIBRATING MESH NEBULIZERS

Mission

Our mission is to create highly integrated drug-device combination products for affordable-best-quality, featuring nebulization of high value therapeutic drugs that include small molecule synthesics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs.

In order to achieve optimal aerosol performance for diverse formulations, we closely work with our partners to tailor the components and parameters of our mesh technology.

By combining the strength of Taiwan's world-class manufacturing industry and a well-established GMP certified manufacturing facility, our products have received approval by multiple health authorities and have been launched in selected regions.
 

Vision

We bring significant value to global pharma partners through a cost efficient and risk minimized pathway, designing combination products that can provide great contributions in the respiratory field.

Company History

Team

Global operations

HCmed’s headquarters is located in Taipei City. Currently, our company counts with a GMP certified manufacturing site in Zhonghe, New Taipei City, while a second site is under construction in Wuxi, China.

Companies and institutions based in the US, Japan, China, and Taiwan are among our main local and foreign investors. HCmed Innovations is constantly expanding its parnerships worldwide, aiming to deliver top-quality inhalation treatment to people around the world.

  • Functional Sites
  • Investors
  • Partners
Wuxi, China: GMP Manufacturing Site
Taipei City: Headquarters and R&D Center
New Taipei City: GMP Manufacturing Site

1:Wuxi, China: GMP Manufacturing Site

2-1:Taipei City: Headquarters and R&D Center

2-2:New Taipei City: GMP Manufacturing Site

1:VIVO Capital

2:DCI Partners

3:H&Q Asia Pacific

4:Cathay Life Insurance | Mega Bank

1:Abbott, Brazil

2:China AstraZeneca, I-Campus Partner